US EditionPEG Alternative Minimizes Immunogenicity from LNP-Based Therapies
Summary by GEN - Genetic Engineering and Biotechnology News…
1 Articles
1 Articles
All
Left
Center
Right
PEG Alternative Minimizes Immunogenicity from LNP-Based Therapies
A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a commonly used ingredient in lipid nanoparticles (LNPs) that may trigger unwanted immune responses in some people. Traditional lipid nanoparticle formulations for mRNA delivery contain the polymer poly(ethylene) glycol (PEG), which is widely used in drug delivery carriers, but has recently been linked to immuno…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
